Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP165192.RArTI0DNMRMFemb_601QlVf3NicjbO-RfiSxU5iIDCGQ8130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165192.RArTI0DNMRMFemb_601QlVf3NicjbO-RfiSxU5iIDCGQ8130_provenance.
• NP405481.RAVXj0v9K7h-Uppt0VhmOjiJt2td_WfrpH7C8cuvW80e8130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405481.RAVXj0v9K7h-Uppt0VhmOjiJt2td_WfrpH7C8cuvW80e8130_provenance.
• NP931426.RAcjdInm7khFwsqGBE3njSMEiBBiQBmVAY_tcODjdqxSs130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931426.RAcjdInm7khFwsqGBE3njSMEiBBiQBmVAY_tcODjdqxSs130_provenance.
• assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP363333.RA755r9NWXLdj36TFAjHCbUQCuc3GFPuO7N0-5V_MEuO4130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363333.RA755r9NWXLdj36TFAjHCbUQCuc3GFPuO7N0-5V_MEuO4130_provenance.
• assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP363336.RAPlKApN1lYoMHqsIJZdiF6u1iyrGfgL_j4S71EGwnQPQ130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363336.RAPlKApN1lYoMHqsIJZdiF6u1iyrGfgL_j4S71EGwnQPQ130_provenance.
• NP363334.RApoqrbQyUV0BfQZEFN6QcLcRK2bLcr27W0t9EvSazsbU130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363334.RApoqrbQyUV0BfQZEFN6QcLcRK2bLcr27W0t9EvSazsbU130_provenance.
• NP557723.RAkwl9oPU-LM8SsfTFym6_hEE_F198gEXdQL89RqAcEfw130_assertion description "[In conclusion, it is important to recognize GISTs that have a specific molecular pathogenesis and to separate them from other mesenchymal tumors with optimal immunostaining for CD117 when making a diagnosis and prognostic classification based on tumor size and MIB-1 grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557723.RAkwl9oPU-LM8SsfTFym6_hEE_F198gEXdQL89RqAcEfw130_provenance.